News 2013

  • GE Healthcare Life Sciences Opens Technology Laboratory at SBC

    29 October 2013

    Chalfont St. Giles and Stevenage , UK - 29 October 2013 . GE Healthcare Life Sciences, a global provider of tools, technologies and services for life science research and for the manufacturing of biopharmaceuticals, today announced the opening of a Technology Laboratory at Stevenage... read more

  • MRC Technology to join innovation network at SBC

    15 October 2013

    Relocation of MRC Technology's drug discovery unit starts next step in campus growth Stevenage and London, UK, October 15 2013 – Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus, and MRC Technology, a life science technology transfer... read more

  • MIMIT joins forces with SBC and AHSC TTOs

    17 September 2013

    MIMIT joins forces with Stevenage Bioscience Catalyst and Academic Health Science Centre TTOs in England to tackle targeted drug delivery particularly in relation to neuro-degenerative disorders. Manchester: Integrating Medicine and Innovative Technology (MIMIT) has joined forces with... read more

  • NanoKTN Helps Pharmidex Find New Facility

    22 August 2013

    Stevenage Bioscience Catalyst, the UK’s First Open Innovation (OI) Bioscience Campus, is New Home for Pharmidex The Nanotechnology Knowledge Transfer Network (NanoKTN – ), one of the UK’s primary knowledge-based networks for Micro and... read more

  • SBC tenant Arachos Pharma funding news

    13 August 2013

    Arachos Pharma awarded Biomedical Catalyst grant to develop new anti-inflammatory medicine Stevenage UK, 13 th August 2013: Arachos Pharma Ltd is a new pharmaceutical company developing novel oral anti-inflammatory medicines. It has been awarded a £1.2 million Biomedical... read more

  • SBC strengthens advisory panel

    24 July 2013

    Stevenage, July 2013 - Stevenage BioScience Catalyst has appointed 3 more experts to join its successful advisory panel. Dr Nick Pay, Dr Berwyn Clarke and Emma Palmer Foster will further contribute to expanding the campus' business incubation activities. Since 2012, nearly 30 businesses... read more

  • Treatments for pain & MS being developed

    25 June 2013

    Cambridge researchers developing new therapies as part of a collaborative programme with industry Two revolutionary treatments which could alleviate pain in people with hypersensitivity to heat, and provide a new regenerative therapy with MS sufferers, are being developed University of... read more

  • SBC to host J&J Innovation Partnering Office

    20 June 2013

    Global healthcare company to access Incubator's Innovation Network Stevenage, UK, June 20 2013 – Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation (OI) bioscience campus, is pleased to announce that Johnson & Johnson Innovation has established... read more

  • Plasticell & Progenitor join SBC's community

    10 June 2013

    Companies seed cell therapy activities at open innovation campus Stevenage, UK, June 10 2013 – Stevenage Bioscience Catalyst (SBC), the... read more

  • CMT summit brings together diverse experts

    26 April 2013

    Hertfordshire LEP sponsorship to create new business opportunities Stevenage, UK, April 26 2013 – Stevenage Bioscience Catalyst (SBC), the... read more

  • SBC Strengthens Team with Marketing, Sales & Events Manager

    16 April 2013

    Miranda Knaggs to join as incubator enters new growth phase Stevenage, UK, April 16 2013 – Stevenage Bioscience Catalyst (SBC), the UK’s first... read more

  • SBC tenant Progenitor Labs secures £4 million financing to progress potentially game-changing regenerative medicine platform

    11 March 2013

    Investment from SR One, GlaxoSmithKline’s Corporate Venture Fund, will fund company’s programme to discover small molecule drugs that regenerate specific tissues of the body. ... read more

  • SBC celebrates first birthday

    1 February 2013

    Tenancy levels on track at end of successful year Stevenage, UK, February 1 2013 – A year has passed since Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation (OI) bioscience campus, opened for business. It celebrates its first birthday with occupancy levels on... read more

  • SR One announces the OneStart £100,000 life sciences business plan competition

    23 January 2013

    22nd January 2013 Stevenage Bioscience Catalyst is delighted to support the £100,000 SR One 'One Start' business plan competition. The competition, which is the largest of its kind in the world, is looking for ideas for innovative life sciences technologies with the potential to positively... read more

  • Stevenage Bioscience Catalyst sponsors workshop at Biotech Showcase 2013

    7 January 2013

    Panel to discuss how open innovation will drive future healthcare Stevenage, UK, January 7 2013 – Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation (OI) bioscience campus, will be debating the role of OI across the biotech and medtech sectors at the prestigious... read more

Funding Partners: